[1]
Krawczyk, P. et al. 2026. THE EFFICACY AND SAFETY OF GLECAPREVIR/PIBRENTASVIR THERAPY IN THE TREATMENT OF HCV INFECTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE – A REVIEW OF CURRENT LITERATURE. International Journal of Innovative Technologies in Social Science. 1, 2(50) (May 2026). DOI:https://doi.org/10.31435/ijitss.2(50).2026.5234.